American Psychedelic Practitioner Association closes

Members received this email on Saturday, June 8th, 2024:

Update on APPA Membership

Dear APPA Community,

It is with heavy hearts that we let you know about a series of changes that will begin to take place within the APPA Community and infrastructure. 

At this time we are drawing our Membership Drive to a close. APPA will no longer be accepting membership renewals or new memberships.  Next week we will begin to unwind the Membership Association completely. For those who did support the membership drive, we appreciate your commitment to a long-term membership and wish that we could continue to support you in this way.

Subsequently, we will no longer be able to offer the online platform as a membership benefit. The platform will no longer be accessible, beginning Monday June 10, at 12pm PST.

In light of these changes, next week we will be automatically refunding any membership dues received in the month of June. 

This has been a very challenging decision to make and many factors have contributed to it,  most prominently: 

• The narrowing scope of legal psychedelic practice now predicted over (at least) the next 12-18 months (including elements such as the uncertainty of timing and/or approval of MDMA-AT) indicates a further prolonged timeline until the majority of practitioners can safely and legally work with psychedelic and entactogenic substances.

• The current philanthropic environment is focused on drug development, and is not currently supporting infrastructure projects like APPA. (see graph “Sources & Uses - 2017-Q1 2024” - APPA falls under “Other” category)

• Despite our best efforts, we were unable to achieve our minimum membership and fundraising goals to support our operations and guidelines projects.

And sometimes, it becomes necessary for the first iteration of a brilliant idea like the APPA to be absorbed back into the environment to make way for something newer and stronger to come forward and take the lead.

Please take care of yourselves, and stand by for further communications from the organization. If you have a moment, we would appreciate you taking this survey about your experience of working with APPA for our future use and case study.

For your continued access and educational use, we have moved a great deal of content from the Community Platform to our website:

• All video replays of our Psychedelic Seminars, Town Halls, and Community Circles are located HERE on our website. 

• All APPA Standards and Guidelines are available HERE on our website.

With warmth, gratitude, and hope for the future,

The APPA Team

Other options for psychedelic clinician organizing:

The Psychedelic Medicine Association

The Psychedelic Medicine Association Is A Society Of Physicians, Therapists, And Health Care Professionals Looking To Advance Their Education On The Therapeutic Uses Of Psychedelic Medicines.

The psychedelic revolution isn’t coming – it’s here. Ketamine is a legal medicine, and MDMA and psilocybin are on the fast track to becoming FDA-approved. However, the majority of healthcare providers on the front lines of patient care are unaware of the burgeoning field of psychedelic-based therapeutics.

What good is revolutionary psychedelic medicine if physicians aren't comfortable talking about them let alone recommending, or even prescribing them?

The Psychedelic Medicine Association (PMA) is a public benefit corporation of healthcare providers aimed at bridging the gap between the advances taking place in the psychedelic research world and medical practitioners.

OPEN FOUNDATION

Advancing psychedelic research and therapies to benefit science, healthcare, and society since 2007.

6 - 8 June, 2024 | PHIL, Haarlem | The Netherlands

Interdisciplinary Conference
on Psychedelic Research

6th Edition of Europe's Premier Psychedelic Research Conference.

Organized biannually by the OPEN Foundation since 2010.